Effect of diurnal variability of heart rate on development of arrhythmia in patients with chronic obstructive pulmonary disease

被引:44
|
作者
Tükek, T
Yildiz, P
Atilgan, D
Tuzcu, V
Eren, M
Erk, O
Demirel, S
Akkaya, V
Dilmener, M
Korkut, F
机构
[1] Istanbul Fac Med, Dept Cardiol, Istanbul, Turkey
[2] Yedikule Chest Dis & Chest Surg Hosp, Yedikule, Turkey
[3] Istanbul Fac Med, Dept Internal Med, Istanbul, Turkey
关键词
heart rate variability; COPD; circadian rhythm; arrhythmia;
D O I
10.1016/S0167-5273(02)00402-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined the possible effect of diurnal variability of heart rate on the development of arrhythmias in patients with chronic obstructive pulmonary disease (COPD). Forty-one COPD patients (M/F: 39/2, mean age: 59 +/- 8.5 years) and 32 (M/F: 27/5, mean age: 57 I I years) healthy controls were included. Twenty-four hour ECG recordings were analyzed for atrial fibrillation (AF) or ventricular premature beats (VPB), and circadian changes in heart rate variability (HRV) were assessed by dividing the 24-h period into day-time (08:00-24:00 h) and night-time (24:00-08:00 h) periods. Night-time total (TP), low frequency (LF) and high frequency (HF) powers were similarly lower from day-time parameters in AF(-) COPD patients (HF 3.91 +/- 1 vs. 4.43 +/- 1.04 ms(2), P = 0.001) and controls (HF 3.95 +/- 0.72 vs. 4.82 +/- 0.66 ms(2), P < 0.001). The LF/HF ratios were also significantly reduced in the same patient groups (AF(-) COPD 1.35 +/- 0.21 vs. 1.27 +/- 0.19, P = 0.04, controls 1.43 +/- 0.14 vs. 1.24 +/- 0.09, P < 0.001). Night-time TP and LF were increased, HF unchanged and LF/HF significantly increased (1.11 +/- 0.25 vs. 1.19 +/- 0.27, P < 0.05) in AF(+) COPD patients. Frequency of VPB was correlated with corrected QT dispersion (QTc(d)) (r = 0.52, P = 0.001) and the day-time/night-time HF ratio (r = 0.43, P = 0.02). Patients with QTc(d) greater than or equal to 60 ms did not have the expected increase in night-time HF and had a statistically insignificant increase in LF/HF ratio. In COPD patients with QTc(d) > 60 ms, circadian changes in HRV parameters were parallel with the controls. We concluded that COPD patients with arrhythmia had circadian HRV disturbances such as unchanged night-time parasympathetic tone and disturbed sympatho-vagal balance in favor of the sympathetic system all day long, which may explain the increased frequency of arrhythmia. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 50 条
  • [41] Phenotyping patients with chronic obstructive pulmonary disease and heart failure
    Becher, Peter Moritz
    Lindberg, Felix
    Benson, Lina
    Hage, Camilla
    Dahlstrom, Ulf
    Rosenkranz, Stephan
    Cosentino, Francesco
    Rosano, Giuseppe M. C.
    Blankenberg, Stefan
    Kirchhof, Paulus
    Braunschweig, Frieder
    Lund, Lars H.
    Savarese, Gianluigi
    ESC HEART FAILURE, 2025, 12 (02): : 900 - 911
  • [42] Pulmonary rehabilitation improves heart rate variability at peak exercise, exercise capacity and health-related quality of life in chronic obstructive pulmonary disease
    Cheng, Shih-Tsung
    Wu, Yao-Kuang
    Yang, Mei-Chen
    Huang, Chun-Yao
    Huang, Hui-Chuan
    Chu, Wen-Hua
    Lan, Chou-Chin
    HEART & LUNG, 2014, 43 (03): : 249 - 255
  • [43] Assessing Autonomic Nervous System Function by Pulse Rate Variability in Patients with Chronic Obstructive Pulmonary Disease
    Hirayama, Yuki
    Takata, Miyako
    Yamasaki, Akira
    Kato, Masahiko
    Burioka, Naoto
    YONAGO ACTA MEDICA, 2023, 66 (01) : 180 - 188
  • [44] Heart Rate Variability Analysis of Healthy Individuals and Patients with Ischemia and Arrhythmia
    Georgieva-Tsaneva, Galya
    Gospodinova, Evgeniya
    DIAGNOSTICS, 2023, 13 (15)
  • [45] Effect of long-acting β2-agonists olodaterol and formoterol on heart rate and blood pressure in chronic obstructive pulmonary disease patients
    Andreas, Stefan
    Bothner, Ulrich
    Trampisch, Matthias
    Haensel, Michaela
    Buhl, Roland
    Alter, Peter
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 52 : 1 - 6
  • [46] Ivabradine Prevents Heart Rate Acceleration in Patients with Chronic Obstructive Pulmonary Disease and Coronary Heart Disease after Salbutamol Inhalation
    Zulkarneev, Rustem
    Zagidullin, Naufal
    Abdrahmanova, Guzel
    Hoppe, Uta C.
    Zagidullin, Shamil
    PHARMACEUTICALS, 2012, 5 (04): : 398 - 404
  • [47] Arrhythmias in patients with chronic obstructive pulmonary disease
    Zaghla, Hanan
    Al Atroush, Hatem
    Samir, Ahmed
    Kamal, Mohamed
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2013, 62 (03): : 377 - 385
  • [48] Effect of mibefradil on heart rate variability in patients with chronic heart failure
    Tjeerdsma, G
    Brouwer, J
    de Kam, PJ
    Haaksma, J
    Crijns, HJGM
    van Veldhuisen, DJ
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 73 (01) : 55 - 60
  • [49] Impact of different corrective filters on heart rate variability in chronic obstructive pulmonary disease: conclusions and recommendations for future research
    Santos-de-Araújo A.D.
    Castello-Simões V.
    Bassi-Dibai D.
    Heubel A.D.
    Marinho R.S.
    Camargo P.F.
    Schafauser N.S.
    Dourado I.M.
    Mendes R.G.
    Roscani M.G.
    Arena R.
    Borghi-Silva A.
    Research on Biomedical Engineering, 2024, 40 (3-4) : 579 - 592
  • [50] Diurnal Variations in Psychological Distress in Chronic Obstructive Pulmonary Disease
    Chan-Thim, Emilie
    Dumont, Marie
    Rizk, Amanda K.
    Parwanta, Zohra
    Pepin, Veronique
    Moullec, Gregory
    REHABILITATION NURSING, 2017, 42 (04) : 210 - 215